Journal of Gastrointestinal Surgery

, Volume 21, Issue 1, pp 94–105

Restitution of Tumor Suppressor MicroRNA-145 Using Magnetic Nanoformulation for Pancreatic Cancer Therapy

  • Saini Setua
  • Sheema Khan
  • Murali M. Yallapu
  • Stephen W. Behrman
  • Mohammed Sikander
  • Shabia Shabir Khan
  • Meena Jaggi
  • Subhash C. Chauhan
2016 SSAT Plenary Presentation

DOI: 10.1007/s11605-016-3222-z

Cite this article as:
Setua, S., Khan, S., Yallapu, M.M. et al. J Gastrointest Surg (2017) 21: 94. doi:10.1007/s11605-016-3222-z

Abstract

Introduction

The functional significance of lost microRNAs has been reported in several human malignancies, including pancreatic cancer (PC). Our prior work has identified microRNA-145 (miR-145) as a tumor suppressor microRNA (miRNA) in pancreatic cancer. The restoration of miR-145 downregulates a number of oncogenes including mucin MUC13, a transmembrane glycoprotein that is aberrantly expressed in pancreatic cancer, thus efficiently inhibiting tumor growth in mice. However, lack of an effective tumor-specific delivery system remains an unmet clinical challenge for successful translation of microRNAs.

Methods

We developed a miRNA-145-based magnetic nanoparticle formulation (miR-145-MNPF) and assessed its anti-cancer efficacy. Physico-chemical characterization (dynamic light scattering (DLS), transmission electron microscopy (TEM) and miR-binding efficiency), cellular internalization (Prussian blue and confocal microscopy), miR-145 restitution potential (quantitative reverse-transcription PCR (qRT-PCR), and anti-cancer efficacy (proliferation, colony formation, cell migration, cell invasion assays) of this formulation were performed using clinically relevant pancreatic cancer cell lines (HPAF-II, AsPC-1).

Results

miR-145-MNPF exhibited optimal particle size and zeta potential which effectively internalized and restituted miR-145 in pancreatic cancer cells. miR-145 re-expression resulted in downregulation of MUC13, HER2, pAKT, and inhibition of cell proliferation, clonogenicity, migration, and invasion of pancreatic cancer cells.

Conclusions

miR-145-MNPF is an efficient system for miR-145 delivery and restitution in pancreas cancer that may offer a potential therapeutic treatment for PC either alone or in conjunction with conventional treatment.

Keywords

Magnetic nanoparticle miR-145 Pancreatic cancer Therapeutics Nanotherapies 

Copyright information

© The Society for Surgery of the Alimentary Tract 2016

Authors and Affiliations

  • Saini Setua
    • 1
  • Sheema Khan
    • 1
  • Murali M. Yallapu
    • 1
  • Stephen W. Behrman
    • 2
  • Mohammed Sikander
    • 1
  • Shabia Shabir Khan
    • 3
  • Meena Jaggi
    • 1
  • Subhash C. Chauhan
    • 1
  1. 1.Department of Pharmaceutical Sciences and Center for Cancer ResearchUniversity of Tennessee Health Science CenterMemphisUSA
  2. 2.Department of SurgeryUniversity of Tennessee Health Science CenterMemphisUSA
  3. 3.Department of Computer ScienceUniversity of KashmirSrinagarIndia

Personalised recommendations